LONDON, 27-3-2015 — /EuropaWire/ — The Higher Education Funding Council for England has allocated £85 million of public funding from the Research Partnership Investment Fund to Russell Group universities. This funding will be matched by universities and matched again by … Read the full press release
Posted in Education, Financial, Management, United Kingdom
Tagged Advanced Steel Research Hub – University of Warwick, Building a New Biology – University of Edinburgh, Centre for Tissue Repair – University of Edinburgh, Chemistry of Health – University of Cambridge, Dr Wendy Piatt, Neurological and Psychiatric Imaging Research and Therapeutics Hub - King’s College London, Research Foundation in Compound Semiconductor Technology – Cardiff University, Russell Group universities, The Higher Education Funding Council for England a
London, UK, 7-1-2014 — /EuropaWire/ — Commenting on reports about university leaders’ pay, Dr Wendy Piatt, Director General of the Russell Group, said: “The salaries of Vice-Chancellors and other senior staff at our universities reflect their roles leading extremely complex, international … Read the full press release
23-9-2013 — /EuropaWire/ — Following the publication of the QS World University Rankings for 2013, Dr Wendy Piatt, Director General of the Russell Group, said: “Russell Group universities continue to be ranked amongst the best in the world, with four in the … Read the full press release
21-8-2013 — /EuropaWire/ — Commenting on the Shanghai Jiao Tong Academic Ranking of World Universities, Russell Group Director General Dr Wendy Piatt, said: “No one should use league tables alone to judge the quality of education and research at universities. However … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
